Scott M. Robertson

Insider Reports History

Entity
Individual
Location
C/O Dice Therapeutics, Inc., 279 E. Grand Avenue, Suite 300, Lobby B, South San Francisco, CA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott M. Robertson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Director Stock Option (Right to Buy) 23.7K Sep 12, 2024 Direct
DICE Therapeutics, Inc. CFO & CBO Common Stock 0 $46.50 Aug 9, 2023 Direct
DICE Therapeutics, Inc. CFO & CBO Restricted Stock Units 0 Aug 9, 2023 Direct
DICE Therapeutics, Inc. CFO & CBO Stock Option (right to buy) 0 Aug 9, 2023 Direct

Insider Reports Filed by Scott M. Robertson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCAX Bicara Therapeutics Inc. Sep 12, 2024 1 $0 4 Sep 16, 2024 Director
BCAX Bicara Therapeutics Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director
DICE DICE Therapeutics, Inc. Aug 9, 2023 12 $0 4 Aug 9, 2023 CFO & CBO
DICE DICE Therapeutics, Inc. May 3, 2023 1 -$685K 4 May 5, 2023 CFO & CBO
DICE DICE Therapeutics, Inc. Jan 27, 2023 2 $0 4 Jan 31, 2023 CFO & CBO
DICE DICE Therapeutics, Inc. Apr 14, 2022 1 $0 4 Apr 19, 2022 CFO & CBO
DICE DICE Therapeutics, Inc. Sep 14, 2021 14 $0 4 Sep 16, 2021 CFO & CBO
DICE DICE Therapeutics, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 CFO & CBO